| Name | Title | Contact Details |
|---|
The CSU is a leader in high-quality, accessible, student-focused higher education. With 23 campuses, almost 427,000 students, and 44,000 faculty and staff, we are the largest, the most diverse, and one of the most affordable university systems in the country. The CSU awards about 99,000 degrees annually and has conferred nearly 2.8 million. The CSU is renowned for the quality of its teaching and for the job-ready graduates it produces. The mission of the CSU is to provide high-quality, affordable education to meet the ever changing needs of the people of California. With its commitment to excellence, diversity and innovation, the CSU is the university system that is working for California.
Metropolitan College. School of Language is a Toronto, ON-based company in the Education sector.
Morgan State University, founded in 1867, is a Carnegie-classified doctoral research institution offering more than 60 academic programs leading to bachelor`s degrees as well as programs at the master`s and doctoral levels. As Maryland`s public urban university, Morgan serves a multiethnic and multiracial student body and seeks to ensure that the doors of higher education are opened as wide as possible to as many as possible.
The College of St. Scholastica is a four-year undergraduate and graduate degree granting institution and the only independent private college in northeastern Minnesota. The 186-acre main campus is set on a ridge overlooking Lake Superior. The College also offers flexible learning options which include accelerated degree programs in St. Paul, St. Cloud, Brainerd, Rochester as well as growing complement of online programs.
HistoSonics Inc. is a new medical device company that is developing Histotripsy, a non-invasive image guided and robotic tissue excision technology that was licensed from the University of Michigan. Histotripsy is a versatile platform that will replace traditional surgical and minimally invasive methods to reduce patient trauma and health care costs. The first clinical application will be treatment of Benign Prostatic Hyperplasia (BPH), a prevalent condition in senior men. The condition affects over two million men in the US and approximately 400,000 are treated surgically each year.